GenWay Log In My Account My Cart
Home Products Services Technologies QC & QA Support Company News & Events
Alphabetical Listing of Primary Antibodies: f| 0-4 | 5-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
Alphabetical Listing of Proteins: f| 0-4 | 5-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
Peptides  |  Secondary Antibodies  |  ELISA Kits
Melanoma [HMB45 + DT101 + BC199] Antibody, Mouse Monoclonal Antibody Printer Friendly Datasheet
Catalog Number: 20-272-192073
Buy Melanoma antibody - Volume:   
  Related Product Names:
- Melanoma antibody; Melanoma; CDKN2; MLM; Melanoma [HMB45 + DT101 + BC199]
- Mouse monoclonal [HMB45 + DT101 + BC199] to Melanoma; Cyclin-dependent kinase inhibitor 2A, isoform 4
- Gene Information -
Information in yellow represents specific gene information and does not necessarily represent specific product details. For more information please contact sales@genwaybio.com.
 Gene Name: Melanoma  Gene Name Synonym: CDKN2; MLM

 Gi #: N/A

 NCBI Acc #: N/A

 Swiss Prot Acc #: Q8N726

 Length (aa): N/A

 Mol. Weight (Da): 18006

 Chrom Location: N/A
 Clone: HMB45 + DT101 + BC199

 Isotype: IgG

 Light chain: kappa

 Immunogen: HMB45 - Pigmented melanoma metastases from LN MART-1 - Recombinant human MART-1 protein

 Antigen Species: Human

 Specificity: The HMB-45 clone reacts with a neuraminidase-sensitive oligosaccharide side chain of a glycoconjugate present in immature melanosomes. The HMB45-reactive antigen is present in cutaneous melanocytes, prenatal and infantile retinal pigment epithelium and melanoma cells and is thought to be oncofetal in nature. This antibody has been shown to label the majority of melanomas. MART-1 recognizes a protein of 18kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 recognizes a subcellular fraction found in melanosomes. The antibody labels melanomas and tumors showing melanocytic differentiation. It does not mark neoplasms of epithelial origin, lymphomas or mesenchymal tumors. Melan-A is a useful addition to melanoma panels as it is apparently specific for melanocytic lesions. Studies have also shown that MART-1 is more sensitive than HMB-45 when labeling metastatic melanomas.

 Positive Control: Metastatic melanoma in lymph node

 Target: Melanoma

 Localization: Cytoplasmic

 Concentration: 0.056 mg/ml

 Storage Buffer: Preservative: Proprietary, not sodium azide or thimerosal. Constituents: PBS, Tissue Culture Supernatant. pH 7.3; Protein carrier.

 Application Note: IHC:For an ABC system, dilute 1:50-100 and incubate for 30-60 minutes at RT. For formalin fixed paraffin embedded sections, the staining intensity of this melanoma cocktail is enhanced by performing heat mediated antigen retrieval using a high pH buffer. The HMB-45 portion of this antibody will stain with citrate buffer, pH 6.0; however, data shows the MART-1 portion of this cocktail may be negative unless a high pH buffer is used. We therefore, strongly recommend that you do not use citrate buffer for this antibody cocktail. It is sometimes difficult to interpret DAB stained melanomas due to endogenous pigment, therefore we recommend you substitute an AEC or a Fast Red substrate protocol

 Cellular Localization: Cytoplasmic

 Source/Host: Mouse

 Purity/Purification: n/a

 Clonality: Monoclonal

 Crossreactivity: Cross-reacts with Human, Rat and Mouse. Not yet tested in other species.

 Format: This antibody is produced in tissue culture supernatant, concentrated and then placed in to PBS pH7.3 with a protein carrier and a proprietary preservative that is not sodium azide or thimerosal.

 Storage: Keep as concentrated solution, aliquot and store at 4C.

 Shipping: Products may be shipped on ice pack or dry ice.
 APPLICATIONS for MELANOMA ANTIBODY:
 IHC-Fr, IHC-P: Tested
 TESTING: (secondary reagents and protocols )
 Not Available
 MELANOMA ANTIBODY TARGET DESCRIPTION:
Synonym Names for Melanoma antibody: Melanoma; CDKN2; MLM; Mouse monoclonal [HMB45 + DT101 + BC199] to Melanoma; Cyclin-dependent kinase inhibitor 2A, isoform 4

HMB-45 and MART-1 are coexpressed in the majority of melanomas, as well as uniquely expressed in certain cases. Thus, the HMB-45 and MART-1 cocktail is potentially more sensitive than HMB-45 or MART-1 alone. MART-1 is a cocktail of clones DT101 and BC199. The combination of HMB-45 and the MART-1 cocktail make this triple antibody cocktail a first-order pan melanoma screener.

Function: Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development.

Subunit: Does not interact with cyclins, CDC2, CDK2, CDK4, CDK5 or CDK6. Binds to BCL6, E2F1, HUWE1, MDM2, MYC, NPM1/B23, TOP1/TOPOI and UBE2I/UBC9. Interacts with TBRG1. Interacts with CDKN2AIP and E4F1.

Subcellular Location: Nucleus, nucleolus (By similarity).

Melanoma [HMB45 + DT101 + BC199] reacts with cross-reacts with human, rat and mouse. not yet tested in other species..

OMIM: 600160; gene. [NCBI / EBI]

Products similar to Melanoma antibody:
 IgG
    CDK4 (cyclin-dependent kinase 4), IgG
    MAGE 1 (ready-to-use), IgG
    Melan A (ready-to-use), IgG
    INK4c, IgG
    beta Actin [AC-15], IgG
 Protein
    CDKN2A Human, Protein
    Melanoma Human, Protein
    Cyclin-dependent kinase 6 inhibitor, Protein
 PRODUCT INTERACTIONS:
 Melanoma [HMB45 + DT101 + BC199] interacts with MDM2 [2A10], IgG (GenWay Catalog #: 20-272-192073).
 Melanoma [HMB45 + DT101 + BC199] interacts with MDM2 [SMP14], IgG (GenWay Catalog #: 20-272-192073).
 Melanoma [HMB45 + DT101 + BC199] interacts with MDM2 [SMP14], IgG (GenWay Catalog #: 20-272-192073).
 Melanoma [HMB45 + DT101 + BC199] interacts with Rabbit anti Mouse MDM2 pS185, IgG (GenWay Catalog #: 20-272-192073).
 Melanoma [HMB45 + DT101 + BC199] interacts with MDM2 [HDM2-323], IgG (GenWay Catalog #: 20-272-192073).
 Melanoma [HMB45 + DT101 + BC199] interacts with MDM2 [MD-219], IgG (GenWay Catalog #: 20-272-192073).
 Melanoma [HMB45 + DT101 + BC199] interacts with MDM2 (ready-to-use), IgG (GenWay Catalog #: 20-272-192073).
SUGGESTED ANITBODY REAGENTS - GenWay has an extensive selection of reagents useful for antibody applications. Find blocking buffers, stop reagents, chemiluminescent substrates, diluents, Immunohistochemistry reagents & more.
Order Confirmation: Sales order confirmations are sent out upon the receipt of all orders. Please contact GenWay if you do not receive a confirmation within 1 business day of submitting your order.

Precautions: Melanoma antibody is for in vitro research use only. Not for use in diagnostics or therapeutic procedures.

Important Notes: During shipment, small volumes of Melanoma antibody vial. For products with volumes of 200 µL or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. Actual concentration, volume and quantity will be printed on the vial's label. Please refer to the vials label for this information.

Copyright: This GenWay TDS is copyrighted. This datasheet is produced based partially on data from Swiss-Prot/TrEMBL and NCBI. To better serve our clients with everything we know about Melanoma antibody, all related information, articles, resources about Melanoma antibody are being stored on our online database. Let us know if you have questions regarding this product.

Disclaimer: For documents and software available from this server, GenWay neither warrants nor assumes any legal liability or responsibility for the accuracy, completeness or utility of any information, product or process disclosed.

GenWay is a Protein and Antibody Solutions Provider. Customer Satisfaction is Our Top Priority.

Thank you for visiting GenWay Biotech's Datasheet. GenWay is the world's leader in chicken, IgY antibody production, producing over 900 quality polyclonal IgY antibodies to date. From our unique recombinant protein production, utilizing a variety of protein expression systems, GenWay's polyclonal IgY antibodies incorporate more epitopes, increasing the success rate for ELISA, western blot, immunohistochemistry (IHC), immunocytochemistry (ICC), and many more immunoassays.
Exact   |  Advanced Search
 
Specific Categories
Antibodies
Secondary Antibodies
Proteins
Custom Antibody
ELISA Kits
Reagents
Products by Pathway
Protein Expression
Cell Line Development
 
 
 
GenWay Biotech, Inc.  6777 Nancy Ridge Drive, San Diego, CA 92121
Tel: (858)458-0866  Fax: (858)458-0833  Email: sales@genwaybio.com
www.genwaybio.com ©1998 - 2010 GenWay Biotech, Inc. - All Rights Reserved